Japanese Encephalitis Morbidity, Mortality, and Disability: Reduction and Control by 2015

This strategic plan, prepared by PATH from the contributions of 17 partner organizations, provides details on priority activities that must be sustained for continued momentum in Japanese encephalitis (JE) control, including improved understanding of disease burden, technical assistance for vaccine introduction, procurement support, and advocacy to keep JE on national, regional, and international agendas.

Author(s): PATH, Armed Forces Research Institute of Medical Sciences, BIKEN, et al.

Published: 2009